SAN JOSE, Calif., May 20, 2011 /PRNewswire/ — BD Biosciences, a
segment of BD (Becton, Dickinson and Company) (NYSE:
BDX), launched today the BD FACSVerse™ Flow Cytometer, a
flexible, reliable and scalable system that can analyze up to 10
parameters and support a wide range of research applications.
“We engineered cutting-edge innovation into the BD
FACSVerse System from the ground up, with three foundations in
mind,” said James Glasscock, President of Cell Analysis, BD
Biosciences. “First, we wanted to provide researchers
with a single system that could handle routine applications along
with complex multi-color experiments with precision and
reproducibility. Second, we sought to streamline workflow and
make the system easy to use with built-in intelligence. Lastly, we
wanted to help protect our customers’ investment by giving
them an upgrade path from 6 parameters up to 10 parameters as well
as multiple optional capabilities that will allow them to meet the
future demands of their research.”
With the new BD FACSuite™ Software System for the BD
FACSVerse Flow Cytometer, users can now automate routine tasks,
such as instrument startup, setup, sample acquisition, and data
analysis, and complete others with minimal clicks The
software package’s modular architecture enables users to multitask,
performing data analysis while the system is acquiring data.
According to Glasscock, the software introduces a powerful new
paradigm that eliminates the need for daily spill over correction,
which is essential for today’s multicolor analysis. BD
FACSuite Software enables assays and experiments to be exported to
other BD FACSVerse Systems around the globe, minimizing commonly
encountered system and user-related variances.
The BD FACSVerse Flow Cytometer has built-in intelligence that
is intended to reduce
‘/>”/>